Cushings syndrome and adrenal axis suppression in a patient treated with ritonavir and corticosteroid eye drops

AIDS

Volumn 25, Issue 10, 2011, Pages 1337-1339

  Molloy, Aoife ^a   Matheson, Nicholas J ^a   Meyer, Paul A R ^a   Chaterjee, Krishna ^b   Gkrania Klotsas, Effrossyni ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; BETAMETHASONE; CORTICOTROPIN; DEXAMETHASONE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EYE DROPS; HYDROCORTISONE; RITONAVIR; TETRACOSACTIDE; CORTICOSTEROID;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ADULT; AVASCULAR NECROSIS; BEDTIME DOSAGE; CASE REPORT; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; CYTOMEGALOVIRUS RETINITIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP PAIN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPHYSIS ADRENAL SYSTEM; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; SIDE EFFECT; VIRUS LOAD; WEIGHT GAIN; ADRENAL CORTEX DISEASE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED;

ADRENAL CORTEX DISEASES; ADRENAL CORTEX HORMONES; CUSHING SYNDROME; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; RITONAVIR;

EID: 79958819819     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328347c09c     Document Type: Letter

References (10)

1. Carr A. HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis 2000; 30 (Suppl 2):S135-S142. (Pubitemid 32268981)
2. Gupta SK, Dube MP. Exogenous Cushing syndrome mimicking human immunodeficiency virus lipodystrophy. Clin Infect Dis 2002; 35:E69-E71.
3. Pessanha TM, Campos JM, Barros AC, Pone MV, Garrido JR, Pone SM. Iatrogenic Cushing's syndrome in a adolescent with AIDSs on ritonavir and inhaled fluticasone. Case report and literature review. AIDS 2007; 21:529-532.
4. Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, et al. Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis 2008; 47:e97-e99.
5. Dort K, Padia S, Wispelwey B, Moore CC. Adrenal suppression due to an interaction between ritonavir and injected triamci-nolone: a case report. AIDS Res Ther 2009; 6:10.
6. Zhou SF, Xue CC, Yu XQ, Li C, Wang G. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit 2007; 29:687-710. (Pubitemid 350190847)
7. Afandi B,Toumeh MS, Saadi HF. Cushing's syndrome caused by unsupervised use of ocular glucocorticoids. Endocr Pract 2003; 9:526-529.
8. Chiang MY-M, Sarkar M, Koppens JM, Milles J, Shah P. Exogenous Cushing's syndrome and topical ocular steroids. Eye 2006; 20:725-727. (Pubitemid 43880593)
9. Krupin T, Mandell AI, Podos SM, Becker B. Topical corticos-teroid therapy and pituitary-adrenal function. Arch Ophthal-mol 1976; 94:919-920.
10. Findlay CA, Macdonald JF, Wallace AM, Geddes N, Donaldson MDC. Childhood Cushing's syndrome induced by betametha-sone nose drops, and repeat prescriptions. BMJ 1998; 317:739-740. (Pubitemid 28414308)